Neudle.com: multiple sclerosis epidemiology of

Differential
(Click to cross reference)

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

adverse drug reaction

algorithm

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anemia

angiography, cerebral

angiography, spinal

antibodies to measles

apraxia

area postrema

area postrema syndrome

atlanto axial dislocation, congenital

autoantibodies

autoimmune disease

autonomic dysfunction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

campylobacter infection

CAT scan, abnormal

cause of death

cavernous sinus, syndrome

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebral cortex

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

corpus callosum, lesion of

cost

cranial neuropathy, multiple

critical care unit

cryptococcal meningitis

cytomegalovirus infection

deep gray nuclei

delirium

dementia

demyelinating disease

diagnostic criteria

diencephalon

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disseminated intravascular coagulation(DIC)

electroencephalogram, abnormalities of

electroencephalogram, brain mapping

electroencephalogram, periodic complexes

emergencies, neurologic

employment

encephalitis

encephalitis, bornavirus

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, metabolic

endemic area

epidemiology of neurology

ergotamine

extinction on double simultaneous stimulation

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

gammaglobulin therapy, intravenous

gender

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, complications

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, prognosis of

head injury

head injury, management of

head injury, mild

head injury, prognosis in

headache

headache, children

headache, post traumatic

headache, severe

headache, thunderclap

headache, unilateral

heatstroke

hemangioma

heralding manifestation

herpes simplex virus

herpes virus infection

herpes zoster

hiccoughs

highly active antiretroviral therapy

Hispanics

HLA

human immunodeficiency virus type 1

hypersegmented polys

hyperthermia

hypotension, systemic

hypothalamus, lesion of

immune reconstitution inflammatory syndrome

immunization, neurologic complications with

immunocompetent

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

incidence

inclusion bodies

inclusion bodies, eosinophilic intranuclear

incontinence, fecal

infantile tremor syndrome

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

leg weakness, bilateral

life expectancy

lipoprotein receptor-related protein 4

lymphoma

lymphoma involving CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

memory, impairment of

mental status, abnormal

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

mortality

motor neuron disease

motor neuron disease, juvenile form

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, diffusion weighted

MRI, field strength, high

MRI, flow void, blood

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, lesion burden

MRI, spinal cord

MRI, spinal cord, increased intramedullary cord signal

MRI, T1 weighted high signal foci

MRS

multiple sclerosis

multiple sclerosis, asymptomatic

multiple sclerosis, cluster

multiple sclerosis, diagnosis of

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, lesion location

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, treatment of

muscle weakness

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, longitudinal

myelitis, transverse

myelopathy

myelopathy, ascending

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

neurologic disease, diagnoses of

neurologic examination

neurologic signs

neurologic symptoms

neurologic testing

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

nonsteroidal anti-inflammatory drug

occupational neurologic disorders

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

orthostatic hypotension

periaqueductal lesion

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

pernicious anemia

personality change

pertussis immunization

plasmapheresis

pleocytosis of cerebrospinal fluid

post concussive syndrome

post infectious polyneuropathy

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

proprioception, abnormal

psychological testing

psychomotor retardation

pyramidal tract dysfunction

quality of life

radicular pain

radiculitis

rapidly fatal neurologic illness

rapidly progressing neurologic illness

recurrent

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

renal failure

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

seizure, immunization causing

sensory loss

sensory loss, cutaneous

septicemia

serologic testing

serologic testing, false negative

spinal cord, lesion of

spinal cord, vascular malformation of

spirochete infection

steroid

steroid therapy, CNS treatment and complications with

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

syphilis, diagnosis and treatment

thalamus, lesion of

thalamus, lesion of-bilateral

tick-borne encephalitis

Tolosa Hunt syndrome

toxoplasmosis, acquired

toxoplasmosis, CNS

treatment of neurologic disorder

tremor

trigeminovascular system

urinary tract infection

vaccination, neurologic complications with

vaccine

vasospasm

vasospasm, cerebral

vibratory sensation, abnormal

visuospatial disturbance

vitamin deficiency

vomiting, intractable

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

white matter disease

white matter disease, periventricular

work loss

zinc

Showing articles 800 to 850 of 4480 << Previous Next >>

Cerebrospinal Fluid Oligoclonal IgG Bands in Patients With Spinal Arteriovenous Malformation and Structural Central Nervous System Lesions
Arch Neurol 57:553-557, Cohen,O.,et al, 2000

Neurologic and Developmental Disability After Extremely Preterm Birth
NEJM 343:378-384,429, Wood,N.S. et al, 2000

Functional Outcomes After Gamma Knife Thalamotomy for Essential Tremor and MS-Related Tremor
Neurol 55:443-446, Niranjan,A. et al, 2000

Poliomyelitic-Like Illness in Central European Encephalitis
Neurol 55:299-302, Schellinger,P.D. et al, 2000

Optic Neuritis in Multiple Sclerosis: An Update
The Neurologist 6:205-213, Chan,J.W., 2000

Disability in Young People and Adults One Year after Head Injury: Prospective Cohort Study
BMJ 320:1631-1635, Thornhill,S. et al, 2000

Trauma to the Central Nervous System May Result in Formation or Enlargement of Multiple Sclerosis Plaques
Arch Neurol 57:1074-1076,1078, Poser,C.M., 2000

Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000

Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000

Acute Aphasia in Multiple Sclerosis
Arch Neurol 57:1207-1209, Devere,T.R. et al, 2000

Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000

Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000

Effect of Interferon B-1b in MS, Assessment of Annual Accumulation of PD/T2 Activity on MRI
Neurol 54:200-206, Zhao,G.J.,et al, 2000

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000

Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000

Total Brain N-Acetylaspartate, A New Measure of Disease Load in MS
Neurol 54:15-19, Gonen,O.,et al, 2000

Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000

Pathologic Damage in MS Assessed by Diffusion-Weighted and Magnetization Transfer MRI
Neurol 54:1139-1144, Cercignani,M.,et al, 2000

Progressive Cerebral Atrophy in MS
Neurol 54:807-812,782, Fox,N.C.,et al, 2000

Glossopharyngeal Neuralgia and MS
Neurol 54:1368-1370, Minagar,S.&Sheremata,W.A., 2000

Primary Neurosarcoidosis:A Diagnostic and Therapeutic Challenge
The Neurologist 6:126-133, Nikhar,N.K.,et al, 2000

Outcome of Surgery for Thoracic Outlet Syndrome in Washington State Workers' Compensation
Neurol 54:1252-1257, Franklin,G.M.,et al, 2000

Multiple Sclerosis and Antecedent Infections
Neurol 54:2307-2310, Marrie,R.A.,et al, 2000

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000

Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000

De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

General Neurologist and Subspecialist Care for Multiple Sclerosis, Patients' Perceptions
Neurol 53:1190-1197, Vickrey,B.G.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999

Showing articles 800 to 850 of 4480 << Previous Next >>